Cargando…
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma
Fibroblast growth factor receptor 3 (FGFR3) is expressed in squamous cell carcinoma of the head and neck (SCCHN) including oropharyngeal squamous cell carcinoma (OPSCC) and is a potential therapeutic target. However, information on its correlation with other relevant cancer related proteins stratifi...
Autores principales: | Nannapaneni, Sreenivas, Griffith, Christopher C., Magliocca, Kelly R., Chen, Wanqi, Lyu, Xueying, Chen, Zhengjia, Wang, Dongsheng, Wang, Xu, Shin, Dong M., Chen, Zhuo G., Saba, Nabil F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904228/ https://www.ncbi.nlm.nih.gov/pubmed/33626078 http://dx.doi.org/10.1371/journal.pone.0247498 |
Ejemplares similares
-
Prognostic implications of peritumoral vasculature in head and neck cancer
por: Evans, Michael, et al.
Publicado: (2018) -
Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline
por: Wang, Dongsheng, et al.
Publicado: (2016) -
Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models
por: Amin, A.R.M. Ruhul, et al.
Publicado: (2021) -
Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status
por: Zhang, Jun, et al.
Publicado: (2017) -
Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients
por: Hu, Guoming, et al.
Publicado: (2018)